Stay updated with breaking news from Global Assessment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These data highlighted which drug, in combination with topical corticosteroids, produced the best efficacy results for those with atopic dermatitis.
Treating eczema twice-daily with ruxolitinib cream, 1.5% led to positive results for children in the age range of 2 to 11 years.
Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the American Journal of Clinical Dermatology.
MOORESVILLE, NC / ACCESSWIRE / May 29, 2024 / Engage2Excel, Inc., an industry-leading provider of recruitment, recognition, and engagement solutions, announces its Recruitment Solutions division is positioned
SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that picankibart (R & D code: IBI112), a recombinant anti-interleukin 23p19 subunit (IL-23p19) antibody injection, has met all...